Coldpine
 

Robert B. Aderholt Periodic Transaction Report

Filed Sep 10, 2025 · House Clerk · 1 transaction

U.S. Representative · R · AL-04 · All trades by Robert B. Aderholt

On September 10, 2025, Rep. Robert B. Aderholt (R-AL-04) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 sale) dated Jul 28, 2025.

The filing covers 1 ticker, including $GSK.

Reported amount ranges sum to $1K–$15K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 44 days.

Source document: House Clerk filing 20032062

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Robert B. Aderholt · Sold $GSK · Jul 28 · $1K–$15K

0.25LOW
Disclosure speedx 0.250.10
Trade sizex 0.250.20
Cluster activityx 0.150.00
Track recordx 0.35default0.50

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Robert B. Aderholt

Get an email the moment Robert B. Aderholt files the next one. Free, no card, no spam.

Follow free →
1
Transactions
0 / 1
Buys / sales
1
Tickers
44d
Longest lag

Tickers in this filing

GSK1

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Jul 28, 2025GSK
GSK plc American Depositary Shares (GSK)
sellSelf$1K–$15K44d

The line under an asset name is the asset type the filer selected on the House form, shown with the House Clerk's label for that code. It is the filer's coding, not a classification by Coldpine.

← All congressional filings, newest firstFiled Sep 10, 2025September 2025 archive

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →